Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00490334 · ClinicalTrials.gov registry record
Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 72
- Enrollment target
NCT00490334: Completed study, sponsored by Stanford University.
NCT00490334 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00490334 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
This research involves assessment of cognitive outcome in childhood cancer as well as evaluation of a cognitive rehabilitation program for improving learning and problem solving difficulties in children with cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-09 |
What the finished NCT00490334 record still lists
NCT00490334 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00490334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00490334 about?
NCT00490334 is a clinical study titled "Assessment and Rehabilitation of Cognitive Impairments in Pediatric Survivors of Cancer". This research involves assessment of cognitive outcome in childhood cancer as well as evaluation of a cognitive rehabilitation program for improving learning and problem solving difficulties in children with cancer.
What is the current status of trial NCT00490334?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2007-08. Estimated completion is 2012-09.
Who is sponsoring clinical trial NCT00490334?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia